At the age of 12 he was referred to the growth clinic because of pronounced retardation of growth and obesity. His height was 112 cm (-4.8 SD), and he weighed 37 kg (50th centile). He had several of the dysmorphic features that are described in children with ring 18 karyotype including a small penis (<2 cm long) with small soft testicles (<2 ml volume) (figure). His sense of smell was normal, and his skeletal age was 9-1 years. Serum thyroxine, thyroid stimulating hormone, prolactin, and cortisol concentrations were all normal. A sequential insulin and arginine stimulation test after priming with 100 ,ug ethinyloestradiol daily for three days confirmed growth hormone deficiency with unrecordable growth hormone concentrations despite adequate hypoglycaemia (4.2 mmol/I1-2 mmolI1). The pituitary sella was small but a brain scan was normal. He was given growth hormone (Somatonorm) 4 units subcutaneously three times a week, and his height velocity (which had been 4-8 cm/year before treatment) increased to 10-8 cm/year during the first full year of treatment.
At the age of 14-3 years he was still prepubertal. His gonadotrophin response to gonadotrophin releasing hormone was poor with a peak measurement of luteinising hormone of 3-1 IU/l and a peak measurement of follicle stimulating hormone of 2-1 IU/l. Basal testosterone concentration was 0 1 nmol/l. The addition of testosterone enanthate 100 mg intramuscularly monthly has accelerated his growth (which at the time of writing was 9-7 cm/year), and induced sexual maturation. 
